Format

Send to

Choose Destination
Cancer Imaging. 2010 Jul 6;10:137-43. doi: 10.1102/1470-7330.2010.0021.

Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage.

Author information

1
Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, Brighton BN1 9RR, UK. b.ganeshan@sussex.ac.uk

Abstract

The aim was to undertake an initial study of the relationship between texture features in computed tomography (CT) images of non-small cell lung cancer (NSCLC) and tumour glucose metabolism and stage. This retrospective pilot study comprised 17 patients with 18 pathologically confirmed NSCLC. Non-contrast-enhanced CT images of the primary pulmonary lesions underwent texture analysis in 2 stages as follows: (a) image filtration using Laplacian of Gaussian filter to differentially highlight fine to coarse textures, followed by (b) texture quantification using mean grey intensity (MGI), entropy (E) and uniformity (U) parameters. Texture parameters were compared with tumour fluorodeoxyglucose (FDG) uptake (standardised uptake value (SUV)) and stage as determined by the clinical report of the CT and FDG-positron emission tomography imaging. Tumour SUVs ranged between 2.8 and 10.4. The number of NSCLC with tumour stages I, II, III and IV were 4, 4, 4 and 6, respectively. Coarse texture features correlated with tumour SUV (E: r = 0.51, p = 0.03; U: r = -0.52, p = 0.03), whereas fine texture features correlated with tumour stage (MGI: rs = 0.71, p = 0.001; E: rs = 0.55, p = 0.02; U: rs = -0.49, p = 0.04). Fine texture predicted tumour stage with a kappa of 0.7, demonstrating 100% sensitivity and 87.5% specificity for detecting tumours above stage II ( p = 0.0001). This study provides initial evidence for a relationship between texture features in NSCLC on non-contrast-enhanced CT and tumour metabolism and stage. Texture analysis warrants further investigation as a potential method for obtaining prognostic information for patients with NSCLC undergoing CT.

PMID:
20605762
PMCID:
PMC2904029
DOI:
10.1102/1470-7330.2010.0021
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center